AU3969793A - Use of nitric oxide/nucleophile complexes for the treatment of cancer - Google Patents

Use of nitric oxide/nucleophile complexes for the treatment of cancer

Info

Publication number
AU3969793A
AU3969793A AU39697/93A AU3969793A AU3969793A AU 3969793 A AU3969793 A AU 3969793A AU 39697/93 A AU39697/93 A AU 39697/93A AU 3969793 A AU3969793 A AU 3969793A AU 3969793 A AU3969793 A AU 3969793A
Authority
AU
Australia
Prior art keywords
cancer
treatment
nitric oxide
nucleophile complexes
nucleophile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39697/93A
Inventor
Larry K Keefer
Chris M Maragos
Joost J Oppenheim
Ji Ming Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
US Government
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services, US Government filed Critical US Department of Health and Human Services
Publication of AU3969793A publication Critical patent/AU3969793A/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39697/93A 1992-04-13 1993-03-29 Use of nitric oxide/nucleophile complexes for the treatment of cancer Abandoned AU3969793A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86775992A 1992-04-13 1992-04-13
US867759 1992-04-13

Publications (1)

Publication Number Publication Date
AU3969793A true AU3969793A (en) 1993-11-18

Family

ID=25350418

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39697/93A Abandoned AU3969793A (en) 1992-04-13 1993-03-29 Use of nitric oxide/nucleophile complexes for the treatment of cancer

Country Status (2)

Country Link
AU (1) AU3969793A (en)
WO (1) WO1993020806A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910316A (en) * 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5691423A (en) * 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5840759A (en) * 1993-10-08 1998-11-24 The United States Of America As Represented By The Department Of Health And Human Services Use of nitric oxide releasing compounds to protect noncancerous cells from chemotherapeutic agents
DE69425331D1 (en) * 1993-10-08 2000-08-24 Us Health USE OF NITROGEN OXID RELEASING COMPOUNDS AS A MEDICINE FOR RADIATION SENSITIZATION FOR HYPOXIC CELLS
US5700830A (en) * 1994-11-22 1997-12-23 The United States Of America As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents for reducing metastasis risk
LV11542B (en) * 1995-03-30 1997-02-20 Latvijas Organiskas Sintezes Instituts Substituted 1,3,9,11-tetraoxa-4,5,7,8-tetraazaundecadien-4,7-dioxides-5,7, preparation and use thereof
US5665077A (en) * 1995-04-24 1997-09-09 Nitrosci Pharmaceuticals Llc Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
US5714511A (en) * 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
WO1998043621A1 (en) * 1997-03-31 1998-10-08 The Children's Medical Center Corporation Nitrosylation to inactivate apoptotic enzymes
AU1770299A (en) * 1997-12-23 1999-07-19 Nycomed Imaging As Nitric oxide releasing chelating agents and their therapeutic use
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
DE19945484A1 (en) * 1999-09-22 2001-04-05 Kolb Bachofen Victoria NO-releasing topically applicable composition
EP1502604A1 (en) * 2000-04-26 2005-02-02 Cellegy Pharmaceuticals, Inc Use of nitric oxide mimetics in cancer treatment
US7678391B2 (en) 2000-04-26 2010-03-16 Queen's University At Kingston Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype
SE0004026D0 (en) * 2000-11-03 2000-11-03 Peter Wiklund New use
US20030068386A1 (en) * 2001-09-05 2003-04-10 Stoyanovsky Detcho A. Method of treating cancerous disease
AU2003230715A1 (en) 2002-03-21 2003-10-08 The University Of Utah Research Foundation In vivo use of glutathionone s-transferase activated nitric oxide donors
FR2872158B1 (en) * 2004-06-28 2006-11-03 Merck Sante Soc Par Actions Si NOVEL DIAZENIUMDIOLATE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE
US9259535B2 (en) 2006-06-22 2016-02-16 Excelsior Medical Corporation Antiseptic cap equipped syringe
US11229746B2 (en) 2006-06-22 2022-01-25 Excelsior Medical Corporation Antiseptic cap
KR20110005798A (en) 2008-03-07 2011-01-19 유타대학연구재단 Activated nitric oxide donors and methods of making and using thereof
US9078992B2 (en) 2008-10-27 2015-07-14 Pursuit Vascular, Inc. Medical device for applying antimicrobial to proximal end of catheter
CN106902405B (en) 2011-07-12 2020-12-11 Icu医学有限公司 Device for delivering antimicrobial agents into a percutaneous catheter
EP3294404A4 (en) 2015-05-08 2018-11-14 ICU Medical, Inc. Medical connectors configured to receive emitters of therapeutic agents
SI3525865T1 (en) 2016-10-14 2023-01-31 Icu Medical, Inc. Sanitizing caps for medical connectors
WO2018204206A2 (en) 2017-05-01 2018-11-08 Icu Medical, Inc. Medical fluid connectors and methods for providing additives in medical fluid lines
US11541220B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Needleless connector with antimicrobial properties
US11541221B2 (en) 2018-11-07 2023-01-03 Icu Medical, Inc. Tubing set with antimicrobial properties
US11400195B2 (en) 2018-11-07 2022-08-02 Icu Medical, Inc. Peritoneal dialysis transfer set with antimicrobial properties
US11517732B2 (en) 2018-11-07 2022-12-06 Icu Medical, Inc. Syringe with antimicrobial properties
US11534595B2 (en) 2018-11-07 2022-12-27 Icu Medical, Inc. Device for delivering an antimicrobial composition into an infusion device
JP2022513096A (en) 2018-11-21 2022-02-07 アイシーユー・メディカル・インコーポレーテッド Antibacterial device with cap with ring and insert
JP2024500319A (en) 2020-12-07 2024-01-09 アイシーユー・メディカル・インコーポレーテッド Peritoneal dialysis cap, system, and method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954526A (en) * 1989-02-28 1990-09-04 The United States Of America As Represented By The Department Of Health And Human Services Stabilized nitric oxide - primary amine complexes useful as cardiovascular agents
US5039705A (en) * 1989-09-15 1991-08-13 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5212204A (en) * 1989-10-18 1993-05-18 The United States Of America As Represented By The Department Of Health And Human Services Antihypertensive compositions and use thereof
US5155137A (en) * 1990-09-20 1992-10-13 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Complexes of nitric oxide with polyamines

Also Published As

Publication number Publication date
WO1993020806A1 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
AU3969793A (en) Use of nitric oxide/nucleophile complexes for the treatment of cancer
AU7819994A (en) Nitric oxide treatment
AU6276194A (en) Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
AP9700939A0 (en) Compounds and methods for the treatment of cancer
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
AU5590696A (en) Use of quinones in the treatment of cancer or AIDS
GB9305470D0 (en) New substituted azetidinones useful in the treatment of cancer
IL101410A0 (en) Formulation for the treatment of cancer
AU1480497A (en) Cancer treatment
EP0577023A3 (en) Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
AU6528494A (en) Nitric oxide combination therapy
AU7770991A (en) Method and composition for the treatment of cancer
ZA922073B (en) New compounds for use in the treatment of cancer
GB9308166D0 (en) Cancer therapy
AU4825993A (en) New compounds for use in the treatment of cancer
GB9218711D0 (en) Skin cancer treatment
AU6671090A (en) Cancer treatments
AU5556094A (en) Nucleotide sequence for treating cancer and infection
AU3747093A (en) Grinder for dental treatment instruments
GB2312375B (en) Agents for treatment of cancer
AU3488193A (en) Nitric oxide treatment for ozone bleaching
AU5165993A (en) Pp14-based therapy
AU5419894A (en) Dental treatment aid
GB9218713D0 (en) Gastrointestinal cancer treatment
GB9226032D0 (en) Treatment of cancer